uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
February 28, 2024 07:05 ET
|
uniQure Inc.
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington’s disease; Up to three years of follow-up data to be presented in mid-2024; Regulatory...
ATN To Host Fourth Quarter And Full Year 2023 Financial Results Conference Call On February 22, 2024
February 07, 2024 11:45 ET
|
ATN International, Inc.
BEVERLY, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ATN International, Inc. (“ATN” or the “Company”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, announced...